Author: Jade Passey
“I refuse to be defined by my diagnosis – Karen Bucknall’s story
Karen Bucknall, 52, from Gloucestershire was diagnosed with a brain tumour in 2021 after she sought an explanation for the headaches she was experiencing throughout her chemotherapy treatment for stage 3 bowel cancer.
72% of UK adults unable to name a single brain tumour symptom
In a survey of 1,000 people in the UK, nearly 3 in 4 are unable to name a single symptom of a brain tumour, The Brain Tumour Charity finds.
Scientists join forces to transform treatments for childhood brain tumours
Experts at The Everest Centre are delivering a cutting-edge program of scientific research to develop pioneering new treatments for children diagnosed with low-grade brain tumours, following major new funding from The Brain Tumour Charity.
“This should never have been part of Ramona’s life”
Ramona Read was just nine-years-old when she was diagnosed with a low-grade pilocytic astrocytoma in 2021. Her mum, Vicky, shares their story ahead of their appearance on Channel 4’s The Dog House – where families are matched with dogs who hope to find their forever home.
Lifestyle coaching may help reduce fatigue and improve mental health for those with a brain tumour.
Offering coaching to promote healthy lifestyles could help reduce severe fatigue for patients following brain tumour treatment, a clinical trial has found.
Pioneering new cancer vaccine planned in England
The government have signed an agreement with German pharmaceutical company BioNTech to ensure their innovative vaccine research comes to England.
Childhood medulloblastoma origin uncovered, opening new doors for treatment
Researchers have found the origin of group 3 and 4 childhood medulloblastoma, which could help develop new treatments for children diagnosed with one of the most common forms of cancerous brain tumour.
Ulixertinib may change childhood brain tumour treatment
New research suggests that ulixertinib may offer one of the first targeted therapies for the most common form of brain tumour in children.
Trial finds DCVax-L can prolong the lives of those living with a Glioblastoma
A major phase III clinical trial has found that novel treatment DCVax®-L can prolong the lives of people diagnosed with a new or recurrent glioblastoma.
World-leading expert appointed as The Brain Tumour Charity neuro-oncology chair at University of Manchester
We are delighted to announce the appointment of the first-ever The Brain Tumour Charity Chair of Translational Neuro-Oncology at The University of Manchester’s Cancer Research Centre (MCRC).